Us company
Buy & Sell Novo Nordisk A/S (NVO) – Novo Nordisk A/S Price Today
Earnings
Valuation Ratios
P/E
P/E
A ratio to value a company, calculated by dividing the current stock price per share by the company's earnings per share (EPS).
P/E
10.26
P/S
P/S
A ratio to value a company, calculated by dividing market capitalization by the company's sales over the past 12 months.
P/S
3.82
EV/EBITDA
EV/EBITDA
A ratio that compares the value of a company—debt included—to the company’s cash earnings less non-cash expenses.
EV/EBITDA
7.68
P/B
P/B
A ratio to value a company, calculated by dividing the company's current stock price per share by its book value per share (BVPS).
P/B
6.14
Profitability
Gross Profit Margin
Gross Profit Margin
A measure of profitability that shows the percentage of gross profits to revenues for a company. It shows how successful the company in generating revenue.
Gross Profit Margin
81.85%
Net Income Margin
Net Income Margin
A measure of profitability that shows the percentage of net income to revenues for a company. It shows how effective a company translates its revenue into profit.
Net Income Margin
37.2%
ROE
ROE
A measure of a company's financial performance, calculated by dividing net income by shareholders' equity
ROE
71.4%
ROA
ROA
A profitability ratio that measures how well a company is generating profits from its total assets.
ROA
23.27%
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions